Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
308.16
-1.73 (-0.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
41
42
Next >
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
Via
Benzinga
Amgen Shares Climb As Late-Stage Lung Cancer Study Meets Primary Endpoint
August 30, 2022
Amgen (NASDAQ: AMGN) has announced top-line results from the global Phase 3 CodeBreaK 200 trial evaluating once daily oral LUMAKRAS (sotorasib) in patients with KRAS G12C-mutated non-small cell lung...
Via
Benzinga
Amgen's Repatha Shows Long Term Lowering Of Bad Cholesterol, Tolerance
August 29, 2022
Via
Benzinga
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
August 29, 2022
These names are benefitting from M&A, clinical data and promising regulatory actions.
Via
Investor's Business Daily
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 23, 2022
Via
Benzinga
Amgen's Return on Invested Capital Overview
August 12, 2022
Via
Benzinga
Analyst Ratings for Amgen
August 05, 2022
Analysts have provided the following ratings for Amgen (NASDAQ:AMGN) within the last quarter:
Via
Benzinga
Amgen Q2 Earnings and Revenues Beat Estimates
August 04, 2022
Amgen came out with quarterly earnings of $4.65 per share.
Via
Talk Markets
Amgen Touts Positive Data From Soliris-Based Biosimilar For Rare Blood Disorder
August 23, 2022
Via
Benzinga
Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million
August 23, 2022
The biopharma buying spree continued Tuesday with glaucoma drugs maker Aerie.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
August 19, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
CNBC's Final Trades: Easterly Government Properties, ExxonMobil, Illinois Tool Works And This Health Care Company
August 18, 2022
On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said Easterly Government Properties Inc (NYSE: DEA) offers a 5.6% yield.
Via
Benzinga
Apple, IBM Are CNBC 'Fast Money' Calls Of The Day
August 17, 2022
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
Via
Benzinga
Amgen Moves to Dismiss Regeneron's Antitrust Case Regarding Cholesterol Drug
August 16, 2022
Via
Benzinga
75 Firms Going Ex-Dividend Next Week, Including Target, Amgen And Chevron
August 13, 2022
Ex-dividend dates are important to dividend investors because one must own a stock prior to its ex-dividend date in order to be eligible to receive its next dividend.
Via
Talk Markets
$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
August 12, 2022
Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 3.82% on an annualized basis producing an average annual return of 11.31%. Currently, Amgen has a market capitalization of...
Via
Benzinga
Senate Finance Committee Expands Amgen's Tax Probe: Report
August 12, 2022
Senator Ron Wyden sent a letter to Amgen Inc (NASDAQ: AMGN) asking what methods the company has used to pay an average effective tax rate of around 12% over the past four years.
Via
Benzinga
3 Best Funds for Aggressive Investors
August 11, 2022
These are the three best funds for aggressive investors. ETFs like BUG, RYT, and BBH can make great investments in the rest of the year.
Via
InvestorPlace
4 Index Funds to Buy and Hold Forever
August 11, 2022
These are the best index funds to buy and hold in August. DIA, ONEQ, RYF and XSD can make great long-term investments.
Via
InvestorPlace
This Is What Whales Are Betting On Amgen
August 09, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Amgen. Looking at options history for Amgen (NASDAQ:AMGN) we detected 10 strange trades.
Via
Benzinga
Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock
August 09, 2022
Mizuho boosted the price target for Karuna Therapeutics, Inc. (NASDAQ: KRTX) from $190 to $276. Karuna Therapeutics shares fell 1.3% to $238.00 in pre-market trading.
Via
Benzinga
Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
August 08, 2022
Via
Benzinga
Two Appealing Biotech Stocks for Two Distinct investors
August 08, 2022
Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles
Via
MarketBeat
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Small Cap Biotechs Perk Up On Dealmaking
August 06, 2022
With M&A picking up we would think smaller deals make sense for large cap biopharma to expand pipelines and complement technology.
Via
Talk Markets
Amgen's Q2 Sales Impacted By Lower Prices, Currency Headwind, Reaffirms FY22 Outlook
August 05, 2022
Via
Benzinga
What Are Whales Doing With Amgen
August 04, 2022
Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Amgen Narrows Sales Outlook Following Plans To Acquire ChemoCentryx
August 04, 2022
The company also reported a second-quarter beat and reiterated its earnings outlook.
Via
Investor's Business Daily
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review
August 05, 2022
The Nasdaq and small caps rose while the S&P 500 is hitting resistance.
Via
Investor's Business Daily
Recap: Amgen Q2 Earnings
August 04, 2022
Amgen (NASDAQ:AMGN) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:02 PM. Here's what investors need to know about the announcement. Earnings Amgen beat estimated earnings by 5.68%,...
Via
Benzinga
ChemoCentryx Shares Are Jumping 110% Thursday: Here's Why
August 04, 2022
Shares of ChemoCentryx, Inc. (NASDAQ: CCXI) are skyrocketing Thursday following a groundbreaking announcement for the biopharmaceutical company. Why Is It Moving?
Via
Benzinga
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
41
42
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.